DFTX FY 2024 Earnings — Definium Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DFTXDefinium Therapeutics, Inc.

$2B

FY 2024 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

-$527,000

Operating Income

-$104M

Net Income

-$109M

EPS (Diluted)

$-0.15

Cash Flow

Operating Cash Flow

-$79M

Free Cash Flow

-$79M

Stock-Based Comp.

$17M

Balance Sheet

Total Assets

$302M

Total Liabilities

$61M

Stockholders' Equity

$241M

Cash & Equivalents

$274M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$527,000	-$3M	+83.3%
Operating Income	-$104M	-$94M	-10.7%
Net Income	-$109M	-$96M	-13.5%